A 57-gene expression signature in B-cell chronic lymphocytic leukemia

Biomedicine and Pharmacotherapy

Volumn 63, Issue 9, 2009, Pages 663-671

  Carlucci, F ^a   Marinello, E ^a   Tommassini, V ^a   Pisano, B ^a   Rosi, F ^a   Tabucchi, A ^a  

^a Sezione di Biochimica   (Italy)

Author keywords

Apoptosis; B CLL; Microarray

Indexed keywords

5' NUCLEOTIDASE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE KINASE; ADENOSINE MONOPHOSPHATE DEAMINASE; ADENYLATE KINASE; ADENYLOSUCCINATE LYASE; CASPASE 6; CASPASE 8; CD38 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; G PROTEIN COUPLED RECEPTOR KINASE 6; GLYCINE TRANSFER RNA LIGASE; INOSINATE DEHYDROGENASE; INTERLEUKIN 18; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 10; PROTEIN BCL XL; PURINE; PURINE NUCLEOSIDE PHOSPHORYLASE; RNA; XANTHINE DEHYDROGENASE;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; MARKER GENE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PURINE METABOLISM; RNA ISOLATION; SIGNAL TRANSDUCTION; SYMPTOM; UNINDEXED SEQUENCE;

5'-NUCLEOTIDASE; APOPTOSIS; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; NAD; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; PURINE NUCLEOTIDES; SIGNAL TRANSDUCTION;

EID: 69049104486     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2009.02.001     Document Type: Article

References (40)

1. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103 (2006) 2257
2. Foon K.A., Rai K.R., and Gale R.P. Chronic lymphocytic leukemia: new insight into biology and therapy. Ann Intern Med 113 (1990) 525
3. Caligaris-Cappio F. Biology of chronic lymphocytic leukemia. Rev Clin Exp Hematol 4 (2000) 5
4. Kay N.E., Hamblin T.J., Jelinek D.F., Dewald G.W., Byrd J.C., Fraga S., et al. Chronic lymphocytic leukemia. Hematology 1 (2003) 193
5. Ghia P., Guida G., Stella S., Gottardi D., Geuna M., Strola G., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia patients at risk of disease progression. Blood 101 (2003) 1262
6. Gentile M., Mauro F.R., Calabrese E., De Propris M.S., Giammartini E., Mancini F., et al. The prognostic value of CD38 expression in chronic lymphocytic leukemia patients studied prospectively at diagnosis: a single institute experience. Br J Haematol 130 (2005) 549
7. Stevenson F.K., and Caligaris-Cappio F. Chronic lymphocytic leukemia: revelation from B cell receptors. Blood 93 (2004) 1732
8. Orchard J.A., Ibbotson R.E., Davis Z., Wiestner A., Rosenwald A., Thomas P.W., et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363 (2004) 105
9. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 94 (2001) 1639
10. Shanafelt T.D., Geyer S.M., and Kay N.E. Prognosis at diagnosis: integrating molecular biology insight into clinical practice for patients with CLL. Blood 103 (2004) 1202
11. Richardson S.J., Matthews C., Catherwood M.A., Alexander H.D., Carey S.B., Farrugia J., et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood 107 (2006) 3584
12. Carlucci F., Rosi F., Di Pietro C., Marinello E., Pizzichini M., and Tabucchi A. Purine nucleotide metabolism: specific aspects in chronic lymphocytic leukemia lymphocytes. Biochim Biophys Acta 1360 (1997) 203
13. Carlucci F., Tabucchi A., Aiuti A., Rosi F., Floccari F., Pagani R., et al. Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency. Clin Chem 1830 (2003) 49
14. Tabucchi A., Carlucci F., Leoncini R., Vannoni D., Consolomagno E., Marinello E., et al. Purine nucleotide metabolism in lymphocytes of B-cell chronic lymphocytic leukemia patients. Biomed Pharmacother 49 (1995) 141
15. Carlucci F., Tabucchi A., Pagani R., and Marinello E. Synthesis of adenine and guanine nucleotides at the "inosinic branch point" in lymphocytes of leukemia patients. Biochim Biophys Acta 1454 (1999) 106
16. Marinello E., Carlucci F., Rosi F., Floccari F., Raspadori D., and Tabucchi A. Purine metabolism in B-cell lymphocytic leukemia: a microarray approach. Nucleosides Nucleotides Nucleic Acids 25 (2006) 1277
17. van Laarhoven J.P., de Gast G.C., Spierenburg G.T., and de Bruyn C.H. Enzymological studies in chronic lymphocytic leukemia. Leuk Res 7 (1983) 261
18. Rosi F., Tabucchi A., Carlucci F., Galieni P., Lauria F., Zanoni L., et al. 5′-Nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia. Clin Biochem 31 (1998) 269
19. Jelinek D.F., Tschumper R.C., Stolovitzky G.A., Iturria S.J., Tu Y., Lepre J., et al. Identification of a global gene expression signature of B-chronic lymphocytic leukemia. Mol Cancer Res 1 (2003) 346
20. Rosi F., Agostinho A.B., Carlucci F., Zanoni L., Porcelli B., Marinello E., et al. Behaviour of human lymphocytic isoenzymes of 5′-nucleotidase. Life Sci 62 (1998) 2257
21. Deaglio S., Capobianco A., Bergui L., Dürig J., Morabito F., Dührsen U., et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 102 (2003) 2146
22. Di Celle P.F., Mariani S., Riera L., Stacchini A., Reato G., and Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87 (1996) 4382
23. Meinhardt G., Wendtner C.M., and Hallek M. Molecular pathogenesis of chronic lymphocytic leukemia: factors and signaling pathways regulating cell growth and survival. J Mol Med 77 (1999) 282
24. Plas D.R., Rathmell J.C., and Thompson C.B. Homeostatic control of lymphocyte survival: potential origins and implications. Nat Immunol 3 (2002) 515
25. Moreno A., Villar M.L., Camara C., Luque R., Cespon C., Gonzalez-Porqué P., et al. Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood 97 (2001) 242
26. Airoldi I., Raffaghello L., Cocco C., Guglielmino R., Roncella S., Fedeli F., et al. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes. Clin Cancer Res 10 (2004) 144
27. Dancescu M., Rubio-Trujillo M., Biron G., Bron D., Delespesse G., and Sarfati M. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176 (1992) 1319
28. Reed J.C. Bcl-2 family proteins. Oncogene 17 (1998) 3225
29. Schena M., Larsson L.G., Gottardo D., Gaidano G., Carlsson M., Nilsson K., et al. Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79 (1992) 2981
30. Kitada S., Andersen J., Akar S., Zapata J.M., Takayama S., Kraiewsky S., et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlation with in vitro and in vivo chemoresponse. Blood 91 (1998) 3379
31. Tsujimoto Y., Louie E., Bashir M.M., and Croce C.M. The reciprocal partners of both the t(14; 18) and the t(11; 14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 2 (1988) 347
32. Efremov D.G., Gobessi S., and Longo P.G. Signaling pathways activated by antigen-receptor engagement in chronic lymphocytic leukemia B-cells. Autoimmun Rev 7 (2007) 102
33. Nuessler V., Stötzer O., Gullis E., Pelka-Fleischer R., Pogrebniak A., Gieseler F., et al. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. Leukemia 13 (1999) 1864
34. Smit L.A., Hallaert D.Y., Spijker R., de Goeij B., Jaspers A., Kater A.P., et al. Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity. Blood 109 (2007) 1660
35. Jones D.T., Ganeshaguru K., Virchis A.E., Folarin N.I., Lowdell M.W., Mehta A.B., et al. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or γ radiation. Blood 98 (2001) 2800
36. Platanias L.C. Map kinase signaling pathways and haematological malignancies. Blood 101 (2003) 4667
37. Farber C.M., Kanganis D.N., Liebes L.F., and Silber R. Antioxidant enzymes in lymphocytes from normal subjects and patients with chronic lymphocytic leukaemia: increased glutathione peroxidase activity in CLL B lymphocytes. Br J Haematol 72 (1989) 32
38. Stamler J.S. Redox signaling: nitrosylation and related target interaction of nitric oxide. Cell 78 (1994) 931
39. Zhao H., Dugas N., Mathiot C., Delmer A., Dugas B., Sigaux F., et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood 92 (1998) 1031
40. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., et al. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 24 9 (2006 September) 1151-1161